Glaxo's New Pharma Head Looks to Move Fast, Especially in Cancer
GlaxoSmithKline Plc, the U.K.’s biggest drugmaker, signaled it will look to speed development of an experimental cancer treatment as part of its ambition to expand in oncology just two years after selling ...